NEW YORK, Feb. 10 (GenomeWeb News) - Tokyo-based Mitsui & Co. said today that it has made an undisclosed equity investment in clinical proteomics firm Correlogic Systems of Bethesda, Md.

The two companies have also signed a memorandum of understanding to "explore the possible creation of a Japan-based joint venture for deployment of Correlogic's diagnostic testing technology," Mitsui said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.